Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'dexfenfluramine' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 248 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Belohlavkova, S; Simak, J; Kokesova, A; Hnilickova, O; Hampl, V
      Fenfluramine-induced pulmonary vasoconstriction: role of serotonin receptors and potassium channels

      JOURNAL OF APPLIED PHYSIOLOGY
    2. Kaddoumi, A; Nakashima, MN; Nakashima, K
      Fluorometric determination of DL-fenfluramine, DL-norfenfluramine and phentermine in plasma by achiral and chiral high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    3. Kaddoumi, A; Nakashima, MN; Wada, M; Kuroda, N; Nakahara, Y; Nakashima, K
      Hplc of (+/-)-fenfluramine and phentermine in plasma after derivatization with dansyl chloride

      JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES

    4. ASHP therapeutic position statement on the safe use of pharmacotherapy forobesity management in adults

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    5. Campbell, ML; Mathys, ML
      Pharmacologic options for the treatment of obesity

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    6. Poston, WSC; Haddock, CK; Dill, PL; Thayer, B; Foreyt, JP
      Lifestyle treatments in randomized clinical trials of pharmacotherapies for obesity

      OBESITY RESEARCH
    7. Callahan, BT; Cord, BJ; Ricaurte, GA
      Long-term impairment of anterograde axonal transport along fiber projection originating in the rostral raphe nuclei after treatment with fenfluramineor methylenedioxymethamphetamine

      SYNAPSE
    8. Prow, MR; Lancashire, B; Aspley, S; Heal, DJ; Kilpatrick, IC
      Additive effects on rat brain 5HT release of combining phentermine with dexfenfluramine

      INTERNATIONAL JOURNAL OF OBESITY
    9. Kaddoumi, A; Kubota, A; Nakashima, MN; Takahashi, M; Nakashima, K
      High performance liquid chromatography with UV detection for the simultaneous determination of sympathomimetic amines using 4-(4,5-diphenyl-1H-imidazole-2-yl)benzoyl chloride as a label

      BIOMEDICAL CHROMATOGRAPHY
    10. Boschmann, M; Adams, F; Klaus, S
      In situ metabolic and hemodynamic response to dexfenfluramine in white adipose tissue of rats

      ANNALS OF NUTRITION AND METABOLISM
    11. Burger, AJ; Charlamb, MJ; Singh, S; Notarianni, M; Blackburn, GL; Sherman, HB
      Low risk of significant echocardiographic valvulopathy in patients treatedwith anorectic drugs

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    12. Russell, BR; Laverty, R
      The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-induced changes in temperature, activity, and neurotoxicity

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    13. Caccitolo, JA; Connolly, HM; Rubenson, DS; Orszulak, TA; Schaff, HV
      Operation for anorexigen-associated valvular heart disease

      JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
    14. Perchenet, L; Hilfiger, L; Mizrahi, J; Clement-Chomienne, O
      Effects of anorexinogen agents on cloned voltage-gated K+ channel hKv1.5

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    15. Higgins, GA; Ouagazzal, AM; Grottick, AJ
      Influence of the 5-HT2C receptor antagonist SB242,084 on behaviour produced by the 5-HT2 agonist Ro60-0175 and the indirect 5-HT agonist dexfenfluramine

      BRITISH JOURNAL OF PHARMACOLOGY
    16. Doucet, E; St-Pierre, S; Almeras, N; Despres, JP; Bouchard, C; Tremblay, A
      Evidence for the existence of adaptive thermogenesis during weight loss

      BRITISH JOURNAL OF NUTRITION
    17. Trifunovic, R; Reilly, S
      Medial versus lateral parabrachial nucleus lesions in the rat: effects on cholecystokinin- and D-fenfluramine-induced anorexia

      BRAIN RESEARCH
    18. Davidoff, R; McTiernan, A; Constantine, G; Davis, KD; Balady, GJ; Mendes, LA; Rudolph, RE; Bowen, DJ
      Echocardiographic examination of women previously treated with fenfluramine - Long-term follow-up of a randomized, double-blind, placebo-controlled trial

      ARCHIVES OF INTERNAL MEDICINE
    19. Mast, ST; Jollis, JG; Ryan, T; Anstrom, KJ; Crary, JL
      The progression of fenfluramine-associated valvular heart disease assessedby echocardiography

      ANNALS OF INTERNAL MEDICINE
    20. Sutton, MS
      Silver lining to the cloud over anorexogen-related cardiac valvulopathy?

      ANNALS OF INTERNAL MEDICINE
    21. Carr, ME; Carr, SL; Martin, EJ; Johnson, BA
      Rapid clot formation and abnormal fibrin structure in a symptomatic patient taking fenfluramine - A case report

      ANGIOLOGY
    22. Weissman, NJ
      Appetite suppressants and valvular heart disease

      AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    23. Mchelakis, ED; Weir, EK
      Anorectic drugs and pulmonary hypertension from the bedside to the bench

      AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    24. Mast, ST; Gersing, KR; Anstrom, KJ; Krishnan, KR; Califf, RM; Jollis, JG
      Association between selective serotonin-reuptake inhibitor therapy and heart valve regurgitation

      AMERICAN JOURNAL OF CARDIOLOGY
    25. Foltin, RW
      Effects of amphetamine, dexfenfluramine, diazepam, and other pharmacological and dietary manipulations on food "seeking" and "taking" behavior in non-human primates

      PSYCHOPHARMACOLOGY
    26. Rowland, NE; Lo, J; Robertson, K
      Acute anorectic effect of single and combined drugs in mice using a non-deprivation protocol

      PSYCHOPHARMACOLOGY
    27. Scheen, AJ; Lefebvre, PJ
      Antiobesity pharmacotherapy in the management of Type 2 diabetes

      DIABETES-METABOLISM RESEARCH AND REVIEWS
    28. Watts, GF; Herrmann, S; Riches, FM
      Effects of diet and serotonergic agonist on hepatic apolipoprotein B-100 secretion and endothelial function in obese men

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    29. Ryan, DH
      Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity

      ENDOCRINE
    30. Ziegler, O; Quilliot, D
      Drug therapy of obesity in type 2 diabetes mellitus.

      DIABETES & METABOLISM
    31. Hirsch, J; Mackintosh, RM; Aronne, LJ
      The effects of drugs used to treat obesity on the autonomic nervous system

      OBESITY RESEARCH
    32. Khan, MA; St Peter, JV; Breen, GA; Hartley, GG; Vessey, JT
      Diabetes disease stage predicts weight loss outcomes with long-term appetite suppressants

      OBESITY RESEARCH
    33. Rossner, S; Sjostrom, L; Noack, R; Meinders, AE; Noseda, G
      Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity

      OBESITY RESEARCH
    34. Deitel, M
      From the editor's desk .... Fenfluramines and heart valves

      OBESITY SURGERY
    35. Jagroop, IA; Mikhailidis, DP
      An investigation of the serotonergic effects of fenfluramine, dexfenfluramine and dexnorfenfluramine using platelets as neuronal models

      PLATELETS
    36. Callahan, BT; Yuan, J; Ricaurte, GA
      Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermine

      SYNAPSE
    37. Carvajal, A; del Pozo, JG; de Diego, IM; de Castro, AMR; Velasco, A
      Efficacy of fenfluramine and dexfenfluramine in the treatment of obesity: A meta-analysis

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    38. Piccinini, M; Rabbone, I; Novi, RF; Alberto, G; Mostert, M; Musso, A; Vai, S; Gamba, S; Rinaudo, MT
      In obese individuals dexfenfluramine corrects molecular derangements reflecting insulin resistance

      INTERNATIONAL JOURNAL OF OBESITY
    39. Finer, N; James, WPT; Kopelman, PG; Lean, MEJ; Williams, G
      One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor

      INTERNATIONAL JOURNAL OF OBESITY
    40. Maccario, M; Grottoli, S; DiVito, L; Rossetto, R; Tassone, F; Ganzaroli, C; Oleandri, SE; Arvat, E; Ghigo, E
      Adrenal responsiveness to high, low and very low ACTH 1-24 doses in obesity

      CLINICAL ENDOCRINOLOGY
    41. Gay, C; Shane-McWhorter, L; Williams, K; Stone, MB
      Physician prescribing of anorexigenics for weight loss in Salt Lake County, Utah

      PHARMACOTHERAPY
    42. Rothman, RB; Carroll, FI
      Opportunities for medication development in obesity

      DRUG DEVELOPMENT RESEARCH
    43. Romach, MK; Sellers, EM; Kaplan, HL; Somer, GR; Gomez-Mancilla, B
      Efficacy of dexfenfluramine in the treatment of alcohol dependence

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    44. Cheetham, SC; Viggers, JA; Slater, NA; Heal, DJ
      Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramine

      NEUROPHARMACOLOGY
    45. Hensrud, DD
      Pharmacotherapy for obesity

      MEDICAL CLINICS OF NORTH AMERICA
    46. Teramae, CY; Connolly, HM; Grogan, M; Miller, FA
      Diet drug-related cardiac valve disease: The Mayo Clinic EchocardiographicLaboratory experience

      MAYO CLINIC PROCEEDINGS
    47. Gardier, AM; Moratalla, R; Cuellar, B; Sacerdote, M; Guibert, B; Lebrec, H; Graybiel, AM
      Interaction between the serotoninergic and dopaminergic systems in d-fenfluramine-induced activation of c-fos and jun B genes in rat striatal neurons

      JOURNAL OF NEUROCHEMISTRY
    48. Patnaude, LA; Undem, BJ; O'Rourke, ST
      Dexfenfluramine-induced contraction of human and rat isolated pulmonary arteries

      EUROPEAN JOURNAL OF PHARMACOLOGY
    49. Cheng, TO
      Fen/phen and valvular heart disease: The final link has now been established

      CIRCULATION
    50. Rothman, RB; Baumann, MH; Savage, JE; Rauser, L; McBride, A; Hufeisen, SJ; Roth, BL
      Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications

      CIRCULATION
    51. Rothman, RB; Redmon, JB; Raatz, SK; Kwong, CA; Swanson, JE; Bantle, JP
      Chronic treatment with phentermine combined with fenfluramine lowers plasma serotonin

      AMERICAN JOURNAL OF CARDIOLOGY
    52. Ellrott, T
      Current efforts in the drug treatment of obesity

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    53. Schmued, L; Slikker, W; Clausing, P; Bowyer, J
      d-fenfluramine produces neuronal degeneration in localized regions of the cortex, thalamus, and cerebellum of the rat

      TOXICOLOGICAL SCIENCES
    54. Ryan, DH; Bray, GA; Helmcke, F; Sander, G; Volaufova, J; Greenway, F; Subramaniam, P; Glancy, DL
      Serial echocardiographic and clinical evaluation of valvular regurgitationbefore, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine

      OBESITY RESEARCH
    55. Steffee, CH; Singh, HK; Chitwood, WR
      Histologic changes in three explanted native cardiac valves following use of fenfluramines

      CARDIOVASCULAR PATHOLOGY
    56. Lane, DA; Kramer, MS
      Determining exposure underreporting in pharmacoepidemiologic case-control studies: Methods and example

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    57. Yeh, SY
      Effects of antihistamines on fenfluramine-induced depletion of indoles in the brain of rats

      SYNAPSE
    58. Chassany, O; Duracinsky, M
      Ethics and clinical trials

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    59. Oleandri, SE; Maccario, M; Rossetto, R; Procopio, M; Grottoli, S; Avogadri, E; Gauna, C; Ganzaroli, C; Ghigo, E
      Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    60. Yamane, F; Tohyama, Y; Diksic, M
      Acute and chronic D-fenfluramine treatments have different effects on serotonin synthesis rates in the rat brain: An autoradiographic study

      NEUROCHEMICAL RESEARCH
    61. Wellman, PJ; Maher, TJ
      Synergistic interactions between fenfluramine and phentermine

      INTERNATIONAL JOURNAL OF OBESITY
    62. Walsh, KM; Leen, E; Lean, MEJ
      The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females

      INTERNATIONAL JOURNAL OF OBESITY
    63. Hauner, H
      The impact of pharmacotherapy on weight management in type 2 diabetes

      INTERNATIONAL JOURNAL OF OBESITY
    64. Scheen, AJ; Lefebvre, PJ
      Pharmacological treatment of obesity: present status

      INTERNATIONAL JOURNAL OF OBESITY
    65. Derby, LE; Myers, MW; Jick, H
      Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    66. Redmon, JB; Raatz, SK; Kwong, CA; Swanson, JE; Thomas, W; Bantle, JP
      Pharmacologic induction of weight loss to treat type 2 diabetes

      DIABETES CARE
    67. Kolanowski, J
      A risk-benefit assessment of anti-obesity drugs

      DRUG SAFETY
    68. Psaty, BM; Weiss, NS; Furberg, CD; Koepsell, TD; Siscovick, DS; Rosendaal, FR; Smith, NL; Heckbert, SR; Kaplan, RC; Lin, DY; Fleming, TR; Wagner, EH
      Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    69. Gillen, G; Porter, JR; Svec, F
      Synergistic anorectic effect of dehydroepiandrosterone and d-fenfluramine on the obese Zucker rat

      PHYSIOLOGY & BEHAVIOR
    70. Rocher, C; Jacquot, C; Gardier, AM
      Simultaneous effects of local dexfenfluramine application on extracellularglutamate and serotonin levels in rat frontal cortex: a reverse microdialysis study

      NEUROPHARMACOLOGY
    71. Soriguer, FJC; Tinahones, FJ
      The principle of precaution and drug treatment for obesity

      MEDICINA CLINICA
    72. Hensrud, DD; Connolly, HM; Grogan, M; Miller, FA; Bailey, KR; Jensen, MD
      Echocardiographic improvement over time after cessation of use of fenfluramine and phentermine

      MAYO CLINIC PROCEEDINGS
    73. Stewart, CW; Slikker, W
      Hyperthermia-enhanced serotonin (5-HT) depletion resulting from D-fenfluramine exposure is preventable.

      LIFE SCIENCES
    74. Cogan, JC
      A new national health agenda: Providing the public with accurate information

      JOURNAL OF SOCIAL ISSUES
    75. Farber, HW; Loscalzo, J
      Prothrombotic mechanisms in primary pulmonary hypertension

      JOURNAL OF LABORATORY AND CLINICAL MEDICINE
    76. Roth, JD; Rowland, NE
      Anorectic efficacy of the fenfluramine phentermine combination in rats: additivity or synergy?

      EUROPEAN JOURNAL OF PHARMACOLOGY
    77. Higenbottam, T; Marriott, H; Cremona, G; Laude, E; Bee, D
      The acute effects of dexfenfluramine on human and porcine pulmonary vascular tone and resistance

      CHEST
    78. Shively, BK; Roldan, CA; Gill, EA; Najarian, T; Loar, SB
      Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine

      CIRCULATION
    79. Christensen, JD; Yurgelun-Todd, DA; Babb, SM; Gruber, SA; Cohen, BM; Renshaw, PF
      Measurement of human brain dexfenfluramine concentration by 19F magnetic resonance spectroscopy

      BRAIN RESEARCH
    80. Rowland, NE; Richmond, RM
      Area postrema and the anorectic actions of dexfenfluramine and amylin

      BRAIN RESEARCH
    81. Adams, C; Cohen, A
      Appetite-suppressant drugs and heart valve abnormalities.

      ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX
    82. Apfelbaum, M; Vague, P; Ziegler, O; Hanotin, C; Thomas, F; Leutenegger, E
      Long-term maintenance of weight loss after a very-low-calorie diet: A randomized blinded trial of the efficacy and tolerability of sibutramine

      AMERICAN JOURNAL OF MEDICINE
    83. Ditschuneit, HH; Flechtner-Mors, M; Johnson, TD; Adler, G
      Metabolic and weight-loss effects of a long-term dietary intervention in obese patients

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    84. Kimmel, SE; Keane, MG; Crary, JL; Jones, J; Kinman, JL; Beare, J; Sammel, M; Sutton, MS; Strom, BL
      Detailed examination of fenfluramine-phentermine users with valve abnormalities identified in Fargo, North Dakota

      AMERICAN JOURNAL OF CARDIOLOGY
    85. Grayburn, PA; Brickner, ME; Rutherford, JD
      The clinical dilemma of anorectic drug use and valvular heart disease

      AMERICAN JOURNAL OF CARDIOLOGY
    86. Munzar, P; Baumann, MH; Shoaib, M; Goldberg, SR
      Effects of dopamine and serotonin-releasing agents on methamphetamine discrimination and self-administration in rats

      PSYCHOPHARMACOLOGY
    87. SCHEEN AJ
      AGGRESSIVE WEIGHT-REDUCTION TREATMENT IN THE MANAGEMENT OF TYPE-2 DIABETES

      DIABETES & METABOLISM
    88. CERULLI J; MALONE M
      OUTCOMES OF PHARMACOLOGICAL AND SURGICAL-TREATMENT FOR OBESITY

      PharmacoEconomics
    89. ORTEGA RM; ANDRES P
      IS OBESITY WORTH TREATING IN THE ELDERLY

      Drugs & aging
    90. Tuder, RM; Radisavljevic, Z; Shroyer, KR; Polak, JM; Voelkel, NF
      Monoclonal endothelial cells in appetite suppressant-associated pulmonary hypertension

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    91. ROLLS BJ; SHIDE DJ; THORWART ML; ULBRECHT JS
      SIBUTRAMINE REDUCES FOOD-INTAKE IN NON-DIETING WOMEN WITH OBESITY

      Obesity research
    92. GONZALEZ AM; SMITH APL; EMERY CJ; HIGENBOTTAM TW
      THE PULMONARY HYPERTENSIVE FAWN-HOODED RAT HAS A NORMAL SEROTONIN TRANSPORTER CODING SEQUENCE

      American journal of respiratory cell and molecular biology
    93. HARITOS VS; CHING MS; GHABRIAL H; GROSS AS; TAAVITSAINEN P; PELKONEN O; BATTAGLIA SE; SMALLWOOD RA; AHOKAS JT
      METABOLISM OF DEXFENFLURAMINE IN HUMAN LIVER-MICROSOMES AND BY RECOMBINANT ENZYMES - ROLE OF CYP2D6 AND 1A2

      Pharmacogenetics
    94. BENGEL D; ISAACS KR; HEILS A; LESCH KP; MURPHY DL
      THE APPETITE-SUPPRESSANT D-FENFLURAMINE INDUCES APOPTOSIS IN HUMAN SEROTONERGIC CELLS

      NeuroReport
    95. VANGAAL LF; WAUTERS MA; DELEEUW IH
      ANTIOBESITY DRUGS - WHAT DOES SIBUTRAMINE OFFER - AN ANALYSIS OF ITS POTENTIAL CONTRIBUTION TO OBESITY TREATMENT

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    96. VEENING JG; COOLEN LM; SPOOREN WJPM; JOOSTEN H; VANOORSCHOT R; MOS J; RONKEN E; OLIVIER B
      PATTERNS OF C-FOS EXPRESSION INDUCED BY FLUVOXAMINE ARE DIFFERENT AFTER ACUTE VS. CHRONIC ORAL-ADMINISTRATION

      European neuropsychopharmacology
    97. DELCROIX M; KURZ X; WALCKIERS D; DEMEDTS M; NAEIJE R
      HIGH-INCIDENCE OF PRIMARY PULMONARY-HYPERTENSION ASSOCIATED WITH APPETITE-SUPPRESSANTS IN BELGIUM

      The European respiratory journal
    98. MCCANN UD; JIE Y; RICAURTE GA
      NEUROTOXIC EFFECTS OF (+ -)FENFLURAMINE AND PHENTERMINE, ALONE AND INCOMBINATION, ON MONOAMINE NEURONS IN THE MOUSE-BRAIN/

      Synapse
    99. BAUMANN MH; ROTHMAN RB
      COMBINED PHENTERMINE FENFLURAMINE ADMINISTRATION AND CENTRAL SEROTONIN NEURONS/

      Synapse
    100. MANNING RM; JUNG RT; LEESE GP; NEWTON RW
      THE COMPARISON OF 4 WEIGHT-REDUCTION STRATEGIES AIMED AT OVERWEIGHT PATIENTS WITH DIABETES-MELLITUS - 4-YEAR FOLLOW-UP

      Diabetic medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/02/20 alle ore 23:44:43